Mucormycosis in Iran: a systematic review

Mycoses

Volumn 59, Issue 7, 2016, Pages 402-415

  Vaezi, Afsane ^a   Moazeni, Maryam ^b   Rahimi, Mohammad Taghi ^c   de Hoog, Sybren ^d   Badali, Hamid ^b,e  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^e MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diabetes; Iran; Mucor; Mucormycosis; Rhizomucor; systematic review

Indexed keywords

ANTIFUNGAL AGENT;

BONE MARROW TRANSPLANTATION; DIABETES MELLITUS; DIABETIC PATIENT; FATALITY; FUNGUS CULTURE; HISTOPATHOLOGY; HUMAN; INFECTION SENSITIVITY; IRAN; MICROSCOPY; MUCOR; MUCORALES; MUCORMYCOSIS; NONHUMAN; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHIZOPUS; SURVIVAL RATE; SYSTEMATIC REVIEW;

EID: 84973643690     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12474     Document Type: Review

References (109)

1. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004; 10(Suppl 1): 31–47.
2. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236–301.
3. Kwon-Chung KJ, Young RC, Orlando M. Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. Am J Clin Path 1975; 64: 544–8.
4. Wang SB, Li RY, Yu J. Identification and susceptibility of Rhizomucor spp. isolated from patients with cutaneous zygomycosis in China. Med Mycol 2011; 49: 799–805.
5. Chkhotua A, Yussim A, Tovar A, et al. Mucormycosis of the renal allograft: case report and review of the literature. Transpl Int 2001; 14: 438–41.
6. Fairley C, Sullivan TJ, Bartley P, Allworth T, Lewandowski R. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient. J Ophthalmol 2000; 107: 555–8.
7. O'Keefe M, Haining WM, Young JD, Guthrie W. Orbital mucormycosis with survival. Br J Ophthalmol 1986; 70: 634–6.
8. Martin-Moro JG, Calleja JM, Garcia MB, Carretero JL, Rodriguez JG. Rhinoorbitocerebral mucormycosis: a case report and literature review. Med Oral Patol Oral Cir Bucal 2008; 13: E792–5.
9. Chakrabarti A, Das A, Sharma A, et al. Ten years' experience in zygomycosis at a tertiary care centre in India. J Infect 2001; 42: 261–6.
10. Cunha M, Nery A, Lima F, Junior JD, Neto JM, Calado N. Rhinocerebral zygomycosis in a diabetic patient. Rev Soc Bras Med Trop 2011; 44: 257–9.
11. Gamaletsou M, Sipsas N, Roilides E. Rhino-orbital-cerebral mucormycosis. Curr Infect Dis Rep 2012; 14: 423–34.
12. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634–53.
13. Lewis RE, Cahyame-Zuniga L, et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 2013; 56: 638–45.
14. Chakrabarti A, Manpreet D. Epidemiology of Mucormycosis in India. Curr Fungal Infect Rep 2013; 7: 287–92.
15. Nithyanandam S, Jacob M, Battu R, Thomas R, Correa M, D'Souza O. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol 2003; 51: 231–6.
16. Shpitzer T, Keller N, Wolf M, et al. Seasonal variations in rhino-cerebral Mucor infection. Ann Otol Rhinol Laryngol 2005; 114: 695–8.
17. Al-Ajam MR, Bizri AR, Mokhbat J, Weedon J, Lutwick L. Mucormycosis in the Eastern Mediterranean: a seasonal disease. J Epidemiol Infect 2006; 134: 341–6.
18. El Herte RI, Baban TA, Kanj SS. Mucormycosis: a review on environmental fungal spores and seasonal variation of human disease. Adv Infect Dis 2012; 2: 76–81.
19. Tabatabai P, Akbaroghlo S. Mucormycosis: report of a case. Tehran Univ Med Sci J 1990; 6: 67–75. [Persian]
20. Moghaddami M, Mohraz M, Shidfar MR. Report of thirteen cases of Mucormycosis. Med J Islam Repub Iran 1993; 7: 175–8.
21. Javadi M, Mohammadi S, Daneshi A. Orbito-rhinocereberal mucormycosis: report of 9 cases. Iran Univ Med Sci J 2001; 8: 397–492. [Persian].
22. Davari HR, Malekhossini SA, Salahi HA, et al. Outcome of mucormycosis in liver transplantation: four cases and a review of literature. Exp Clin Transplant 2003; 1: 147–52.
23. Kassaian AA, Bayani M, Nakhjavanis N. Kidney and peritoneal mucormycosis in a patient with thalassemia. Semnan Univ Med Sci J 2003; 4: 191–2. [Persian].
24. Geramizadeh B, Kheirandish P, Fatheezadeh P. Diagnosis of subcutaneous mucormycosis with fine needle aspiration: a rare case report. Med J Islam Repub Iran 2004; 18: 281–3.
25. Nateghian A, Karimi A. Rhinocereberal mucormycosis: report of 6 cases. Feiz 2004; 30: 96–104. [Persian].
26. Hedjazi ME, Adibpour M, Jamali R. A case report of pulmonary mucormycosis in a diabetic patient. Med J Tabriz 2004; 61: 81–5.
27. Shoja MR, Dabir-Moghadam P. Rhino-Orbital mucormycosis after kidney transplantation. Iran J Ophthalmol 2004; 16: 64–71.
28. Tayyebi-Meybodi N, Amouian S, Mohammadian-Roashan N. Renal allograft mucormycosis: report of two cases. Urology J UNRC IUA 2005; 2: 54–6.
29. Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol 2005; 262: 932–8.
30. Mirsadraee M, Towhidi M, Attaran D, Sharifi N, Ghiasi Moghadam T, Sadrizadeh A. Mucormycosis of the lung, a rare cause for lung cavitations. case report. Iran J Otorhinolaryngol 2006; 18: 43–8.
31. Aslani J, Eizadi M, Kardavani B, et al. Mucormycosis after kidney transplantations: report of seven cases. Scand J Infect Dis 2007; 39: 703–6.
32. Fahimzad A, Chavoshzadeh Z, Abdollahpour H, Klein C, Rezaei N. Necrosis of nasal cartilage due to mucormycosis in a patient with severe congenital neutropenia due to HAX1 deficiency. J Investig Allergol Clin Immunol 2008; 18: 469–72.
33. Hashemzadeh S, Tubbs RS, Fakhree MBA, Shoja MM. Mucormycotic pseudoaneurysm of the common carotid artery with tracheal involvement. Mycoses 2008; 51: 347–51.
34. Malek F, Malek M, Toosi J, Tamadon MR, Zahmatkesh M. A case of pulmonary mucormycosis with limited clinical signs and symptoms in a controlled diabetic patient. Semnan Univ Med Sci J 2008; 10: 73–7. [Persian].
35. Miladipour A, Ghanei E, Nasrollahi A, Moghaddasi H. Successful treatment of mucormycosis after kidney transplantation. Iran J Kidney Dis 2008; 2: 163–6.
36. Nouri-Majalan N, Moghimi M. Skin mucormycosis presenting as an erythema-nodosum-like rash in a renal transplant recipient: a case report. J Med Case Rep 2008; 2: 112.
37. Azarkar Z, Mousavi SG, Zardast M. A case report of rhinocerebral mucormycosis. J Birjand Univ Med Sci 2008; 15: 103–8. [Persian].
38. Ahmadpoor P, Makhdoomi K, Samarehee R, Eelkhanii B, Moghadam AG, Parvaresh A. A case Report of Rhino- sino- orbital mucormycosis in a renal transplant recipient. Urmia Med J 2009; 20: 320–3. [Persian].
39. Chitsaz S, Bagheri J, Mandegar MH, Rayatzadeh H, Razavi J, Azadi L. Extensive sino-orbital zygomycosis after heart transplantation: a case report. Transplant Proc 2009; 41: 2927–9.
40. Golshiri-Esfahani A, Shabani Z, Gooini FL, Mokhtaree M. Nasal and paranasal sinus mucormycosis, Endoscopic surgery with protection of vital organs function. J Rafsanjan Univ Med Sci 2009; 8: 151–8. [Persian].
41. Meydani M, Soheilipoor S, Barzegar F, Heidarpour M, Shakeri H. A case of temporal arteritis associated with mucoromycosis. J Isfahan Univ Med Sci 2009; 92: 56–61. [Persian].
42. Mohammadi G. Maxillary sinus mucormycosis mimicking sinus malignancy. Pak J Med Sci 2009; 25: 872–4.
43. Parham M, Abbasi M, PourNodoshan KA, Norouzi M, Mehran N. A rare case report of tracheal Mucormycosis in a patient with diabetes. J Qom Univ Med Sci 2009; 3: 57–61. [Persian].
44. Paydar S, Baezzat S, Fazelzadeh A, Geramizadeh B. A case of gastric zygomycosis in a diabetic patient successfully treated with total gastrectomy. Middle East J Dig Dis 2010; 2: 46–8.
45. Baezzat SR, Fazelzadeh A, Tahmasebi S, Kumar PV. Primary breast mucormycosis, a case report. Iran Red Crescent Med J 2011; 13: 208–9.
46. Berjis N, Hashemi SM, Sanei MH, Ghasemi- BH. Mucormycosis of subglote and trachea, a case report. J Isfahan Univ Med Sci 2010; 28: 1084–7. [Persian].
47. Gharechahi J, Mir Mortazavi A. An obturator-eye combination prosthesis using magnets: a clinical report. J Mash Dent Sch 2011; 35: 237–42. [Persian].
48. Mohebbi A, Jahandideh H, Harandi AA. Rare presentation of rhino-orbital-cerebral zygomycosis: bilateral facial nerve palsy. Case Rep Med 2011; 2011: 216404. doi:10.1155/2011/216404.
49. Yazdani J, Nezafati S, Rta SA, Ghavimi MA, Ghoreyshizade A. Mucormycosis in a healthy patient: a case report. Med J Tabriz 2011; 33: 98–101. [Persian].
50. Abtahi SM, Omrani M, Karimifar M, Eshaghian A, Kachuei M, Momeni A. Wegener's granulomatosis and mucoromycosis: a case study and review of literature. Adv Biomed Res 2012; 1: 23.
51. Arjmand R, Karimi A, Sanaei Dashti A, Kadivar M. A child with intestinal basidiobolomycosis. Iran J Med Sci 2012; 37: 134–6.
52. Azarpira N, Ashraf MJ, Kazemi K, Khademi B. Rhinomaxillary mucormycosis in a renal transplant recipient: case report. Exp Clin Transplant 2012; 10: 605–8.
53. Badiee P, Jafarpour Z, Alborzi A, Haddadi P, Rasuli M, Kalani M. Orbital mucormycosis in an immunocompetent individual. Iran J Microbiol 2012; 4: 210–4.
54. Geramizadeh B, Kazemi K, Shamsaifar AR, Bahraini A, Nikeghbalian S, Malekhosseini SA. Isolated renal mucormycosis after liver transplantation:an unusual case report. Iran Red Crescent 2012; 14: 447–50.
55. Khodayari A, Mashhadiabbas F, Nasabi Z, Khojasteh A. Rhino- orbitocereberal mucormycosis in a patient without history of underlying disease: a case report and literature review. J Dent Sch 2012; 30: 256–60. [Persian].
56. Mohammadi A, Mehdizadeh A, Ghasemi-Rad M, Habibpour H, Esmaeli A. Pulmonary mucormycosis in patients with diabetic ketoacidosis: a case report and review of literature. Tuberk Toraks 2012; 60: 66–9.
57. Abdolsamadi H, Zarabadipoor M, Saati S, Torkzaban P, Ariamanesh H, Ahmadi-Motamayel F. A successful treatment of an extensive maxillary perforation resulting from mucormycosis. J Mash Dent Sch 2013; 36: 335–40. [Persian].
58. Ahmadinejad Z, Khazraiyan H, Ghanbari F, Ahmadi B, Gerami SM. Cutaneous mucormycosis in a diabetic patient following traditional dressing. Case Report Dermatol Med 2013; 2013: 3. Article ID 894927.
59. Bojdy A, Habibzadeh- Shojaie SR, Farid GA, et al. Cutaneus mucormycosis (zygomycosis) in a kidney transplant recipient: recovery after amphotericin therapy. Adv Biol Res 2013; 4: 275–9.
60. Ebadi M, Alavi S, Ghojevand N, Kazemi Aghdam M, Kaji Yazdi M, Zahiri A. Infantile splenorenopancreatic mucormycosis complicating neuroblastoma. Pediatr Int 2013; 55: e152–5.
61. Erami M, Shams-Ghahfarokhi M, Jahanshiri Z, Sharif A, Razzaghi-Abyaneh M. Rhinocerebral mucormycosis due to Rhizopus oryzae in a diabetic patient: a case report. J Mycol Med 2013; 23: 123–9.
62. Heydari AA, Fata A, Mojtabavi M. Chronic cutaneus mucormycosis in an immunocompetent female. Iran Red Crescent 2013; 15: 254–5.
63. Pourahmad M, Sepidkar A, Farokhnia MH, Tadayon SM, Salehi H, Zabetian H. Mucormycosis after scorpion sting: case report. Mycoses 2013; 56: 589–91.
64. Sanavi S, Afshar R, Afshin-Majd S. Rhino-orbitocerebral mucormycosis in a patient with idiopathic crescentic glomerulonephritis. Saudi J Kidney Dis Transpl 2013; 24: 768–72.
65. Sarrami AH, Setareh M, Izadinejad M, Afshar-Moghaddam N, Baradaran-Mahdavi MM, Meidani M. Fatal disseminated mucormycosis in an immunocompotent patient: a case report and literature review. Int J Prev Med 2013; 4: 1468–71.
66. Mamani M, Torkaman F. Mucormycosis presenting as acute otitis media. Sci J Hamadan Univ Med Sci 2013; 20: 86–90. [Persian].
67. Bameshki SA, Tabari M, Sheybani S. Delayed emergence from anesthesia: a case report. Med J Mashad Univ Med Sci 2014; 6: 383–7. [Persian].
68. Mohammadi GR, Kavossi A, Razyany Y, Prvynyannasab AM, Mohammadi GR. Rhinocerebral mucormycosis: report of two cases. Neyshabur Univ Med Sci J 2014; 2: 10–3. [Persian].
69. Mohammadi R, Nazeri M, Sayedayn SM, Ehteram H. A successful treatment of rhinocerebral mucormycosis due to Rhizopus oryzae. Res Med Sci J 2014; 19: 72–4.
70. Davuodi S, Dehghan Manshadi SA, Salehi MR, Yazdi F, Khazravi M, Taghizade Fazli J. Case report. Exp Clin Transplant 2015; 13: 82–5.
71. Walther G, Pawłowska J, AlastrueyIzquierdo A, et al. DNA barcoding in Mucorales: an inventory of biodiversity. Persoonia 2013; 30: 11–47.
72. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis 2012; 54(Suppl 1): S55.
73. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–21.
74. Mohindra S, Mohindra S, Gupta R, Bakshi J, Gupta SK. Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses 2007; 50: 290–6.
75. Teixeira C, Medeiros P, Leushner P, Almeida F. Rhinocerebral mucormycosis: literature review apropos of a rare enfily. BMJ Case Rep 2013: doi:10.1136/bcr-2013-008552.
76. Bitar D, Van Cauteren D, Lanternier F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis 2009; 15: 1395–401.
77. Kriengkauykiat J, Ito J, Dadwal S. Epidemiology and treatment approaches in management of invasive fungal infections. Clin Epidemiol 2011; 3: 175–91.
78. Sarvestani A, Pishdad G, Bolandparvaz S. Epidemiology and clinical characteristics of mucormycosis in patients with leukemia; a 21-year experience from Southern Iran. Bull Emerg Trauma 2014; 2: 38–43.
79. Salazar M, Restrepo A, Stevens D. Inhibition by estrogens of conidium-to-yeast conversion in the fungus paracoccidioides brasiliensis. Infect Immun 1988; 56(3): 711–3.
80. Bisdas S, Lenarz M, Becker H. Rhinocerebral mucormycosis. Klin Neuroradiol 2003; 13: 213–7.
81. Jindal S, Kulkarni S, Sheikh S, Chandar V, Bhatnagar D, Aggarwal A. Invasive rhinocerebral mucormycosis: a case report with a review of the literature. Oral Radiol 2008; 24: 42–8.
82. Petrikkos G, Skiada A, Sambatakou H, et al. Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis 2003; 22: 753–6.
83. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis 2012; 54(Suppl 1): S16–22.
84. Kontoyiannis DP, Azie N, Franks B, Horn DL. Prospective antifungal therapy (PATH) alliance((R)): focus on mucormycosis. Mycoses 2014; 57: 240–6.
85. Kursun E, Turunc T, Demiroglu YZ, Aliskan HE, Arslan AH. Evaluation of 28 cases of mucormycosis. Mycoses 2015; 58: 82–7.
86. Chinn RY, Diamond RD. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis. Infect Immun 1982; 38: 1123–9.
87. Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, Mucor and Lichtheimia species. Clin Microbiol Rev 2011; 24: 411–45.
88. Institute of Medicine of the National Academy of Sciences. Damp Indoor Spaces and Health. Washington, DC: National Academy of Sciences, 2004.
89. Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infec 2011; 17: 1859–67.
90. Chakrabarti A, Das A, Mandal J, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol 2006; 44: 335–42.
91. Tacke D, Koehler P, Markiefka BA, Cornely O. Our 2014 approach to mucormycosis. Mycoses 2014; 57: 519–24.
92. Chakrabarti A, Rudramurthy SM, Kale P, et al. Epidemiological study of a large cluster of fungaemia cases due to Kodamaea ohmeri in an Indian tertiary care centre. Clin Microbiol Infect 2014; 20: O83–9.
93. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005; 18: 556–69.
94. Lass-Florl C. Zygomycosis: conventional laboratory diagnosis. Clin Microbiol Infec 2009; 15(Suppl 5): 60–5.
95. Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005–2007). Clin Infect Dis 2012; 54(Suppl 1): S35–43.
96. Zeka A, Tasbakan M, Pullukcu H, Sipahi O, Arda B. Evaluation of zygomycosis cases by pooled analysis method reported from Turkey. Mikrobiol Bul 2003; 47: 708–16.
97. Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis 2008; 47: 364–71.
98. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009; 48: 1743–51.
99. Chowdhary A, Kathuria S, Singh PK, et al. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India. Mycoses 2014; 57(Suppl 3): 97–107.
100. Ibrahim AS, Spellberg B, Avanessian V, Fu Y, Edwards JE Jr. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun 2005; 73: 778–83.
101. Valentini CG, Candoni A, Fianchi L, et al. Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies. Mycoses 2010; 53: 89–92.
102. Jung SH, Kim SW, Park CS, et al. Rhinocerebral Mucormycosis: consideration of prognostic factors and treatment modality. Auris Nasus Larynx 2009; 36: 274–9.
103. Pagano L, Offidani M, Fianchi L, et al. Mucormycosis in hematologic patients. Haematologica 2004; 89: 207–14.
104. Pagano L, Valentini CG, Fianchi L, Caira M. The role of neutrophils in the development and outcome of zygomycosis in haematological patients. Clin Microbiol Infect 2009; 15: 33–6.
105. Chakrabarti A, Singh R. The emerging epidemiology of mould infections in developing countries. Curr Opin Infect Dis 2011; 24: 521–6.
106. Meis JF, Chakrabarti A. Changing epidemiology of an emerging infection: zygomycosis. Clin Microb Infect 2009; 15(Suppl 5): 10–4.
107. Pagano L, Valentini CG, Posteraro B, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother 2009; 21: 322–9.
108. Saegeman V, Maertens J, Meersseman W, Spriet I, Verbeken E, Lagrou K. Increasing incidence of mucormycosis in university hospital, Belgium. Emerg Infect Dis 2010; 16: 1456–8.
109. Chakrabarti A, Singh R. Mucormycosis in India: unique features. Mycoses 2014; 57(Suppl 3): 85–90.